OncoAlvo.: Technological Innovation Optimised for the Personalisation of Oncology Therapy (Q2866833): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in pt, en, fr, de, nl, it, es, et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, da, ro, sv, and other parts: Adding translations: et, lt, it, fr, hr, el, en, sk, fi, pl, hu, nl, cs, lv, ga, sl, es, bg, mt, pt, da, ro, de, sv,) |
(Changed label, description and/or aliases in en, pt: Fixing missing labels.) |
||
label / pt | label / pt | ||
OncoAlvo .: Inovação Tecnológica Otimizada para a Personalização da Terapia Oncológica | |||
label / en | label / en | ||
OncoAlvo.: Technological Innovation Optimised for the Personalisation of Oncology Therapy |
Revision as of 18:20, 23 August 2022
Project Q2866833 in Portugal
Language | Label | Description | Also known as |
---|---|---|---|
English | OncoAlvo.: Technological Innovation Optimised for the Personalisation of Oncology Therapy |
Project Q2866833 in Portugal |
Statements
349,140.0 Euro
0 references
467,816.0 Euro
0 references
74.63 percent
0 references
1 March 2016
0 references
1 March 2018
0 references
HEARTGENETICS GENETICS AND BIOTECHNOLOGY, S.A.
0 references
Cantanhede
0 references
Identifiers
CENTRO-01-0247-FEDER-010500
0 references